Holds 2 active US DMFs for rifampin, filing since 1998. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds 2 active US DMFs for rifampin, filing since 1998. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for rifampin, filing since 1998. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.
Holds 2 active US DMFs for rifampin, filing since 1998. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for rifampin, filing since 1998. Its 2022 FDA inspection closed as VAI.
Registered with DAV (Vietnam) for rifampin. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for rifampin. Its GMP is recognised in 1 market.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for freeFixed-dose combinations containing rifampin. Each page leads with the verified API makers of every component.